Incontinentia Pigmenti Common Deletion Analysis

Casandra

Casandra Test Code BA94834Version 1 (DRAFT)

Performing Lab

Lab Baylor GeneticsLab Test ID 6036CPT Code 81479

Incontinentia Pigmenti Common Deletion Analysis

Clinical Use

Use

Incontinentia pigmenti (IP) is a rare ectodermal dysplasia disorder mainly affecting females due to its X-linked dominant inheritance pattern. The condition is primarily marked by progressive changes in the skin, hair, teeth, vasculature, and central nervous system, beginning at birth or early infancy. Key stages of skin involvement include blister-like lesions, wart-like lesions, hyperpigmentation, and eventually atrophic changes. Affected individuals may also show varied anomalies in their dentition and hair. Males with IP typically exhibit a more severe phenotype and a high likelihood of lethality due to the absence of the IKBKG protein during early development. Hence, recognition of this genetic condition is vital for appropriate clinical management and family planning, particularly in suspected cases and for those with familial history or planning pregnancy.

Special Instructions

For sample collection, a skin biopsy should be taken from a central area such as the buttock or thigh to maximize cell viability, and must be placed in RPMI media or sterile saline. Blood should be collected in an EDTA tube, with strict shipping conditions to ensure sample integrity. All samples must arrive within specified timeframes to ensure accurate results.

Limitations

Results from the common deletion analysis may be influenced by several factors, such as the type and quality of the specimen collected. In cases where IKBKG gene variants might not involve exons 4-10, testing may yield false negatives. Additionally, special attention should be given regarding mosaicism or atypical sex chromosomes in males, leading to variable expression of IP, reinforcing the necessity of comprehensive genetic counseling for affected families.

Test Details

New York Approved